Med. praxi. 2012;9(5):250-255

Overview of respiratory devices for respiratory hygiene in practice

Mgr.Petra Žurková, prof.MUDr.Jana Skřičková, CSc.
Klinika nemocí plicních a TBC, LF MU a FN Brno

Obstructive and restrictive pulmonary diseases show a decrease in lung fuction, respiratory muscle strength, hypoxia and hypecapnia,

thereby contributing to greater morbidity and mortality. The non-pharmacological therapy for these patients is the possibility of using

wind aids under the expert guidance of a physiotherapist or doctor. They are mainly used for the facilitation and the removal of bronchial

secretions from the respiratory tract and respiratory muscles maintain strength and thereby increase lung function and quality of life. This

article aims to give report of breathing instruments and their practical application, which are normally used to respiratory hygiene.

Keywords: bronchial secretion, cough, devices for respiratory physiotherapy

Published: May 31, 2012  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Žurková P, Skřičková J. Overview of respiratory devices for respiratory hygiene in practice. Med. praxi. 2012;9(5):250-255.
Download citation

References

  1. Hodges PW, Heijnen I, Gandevia SE. Postural activity of the diaphragm is reduced in humans when respiratory demand increases. J Physiol 2001; 537: 999-1008. Go to original source...
  2. Vojta V, Peters A. Vojtův princip: svalové souhry v reflexní lokomoci a motorická ontogeneze. Praha. Grada.
  3. Čápová J. Terapeutický koncept. Bazální programy a podprogramy. Ostrava 2008. Repronis. 119 s. ISBN: 978-80-732 9-180-8.
  4. Kolář P, et al. Rehabilitace v klinické praxi. Praha. Galén 2009: 713. ISBN: 978-80-7262-657-1.
  5. http://www.soundcare.ca/pm_copd.htm
  6. www.asqa.cz.
  7. Basoglu OK, Atasever A, Bacakoglu F. The efficacy of incentive spirometry in patients with COPD. Respirology 2005; 10: 349-353. Go to original source... Go to PubMed...
  8. Hall
  9. American Association for Respiratory Care (AARC). Incentive spirometry. AARC clinical practice guidelines. Respir Care 1991; 36(12): 1402-1405.
  10. Weindler J, Kiefer RT. The efficacy of postoperative incentive spirometry is influenced by the device - specific imposed work of breathing. Chest 2001; 119(6): 1558-1564. Go to original source... Go to PubMed...
  11. www.harrned.eu.
  12. Gosselink R, Schrever K, Cops P, et al. Incentive spirometry does not enhance recovery after thoracic surgery. Crit Care Med 2000; 28: 679-683. Go to original source... Go to PubMed...
  13. Agostini P, Singh S. Incentive spirometry following thoracis surgery: what should web e doing? Physiotherapy 2009; 95: 76-82. Go to original source... Go to PubMed...
  14. McIlwaine M, Wong LT, Peacock D, Davidson AG. Long-term comparative trial of positive expiratory pressure versus oscillating positive expiratory pressure (flutter) physiotherapy in the treatment of cystic fibrosis. J Pediatr 2001; 138: 845-849. Go to original source... Go to PubMed...
  15. Gaskin L, Corey M, Shin J, Reisman JJ, Thomas J, Tullis DE. Long-term trial of conventional postural drainage and percussion versus positive expiratory pressure. Pediatr Pulmonol 1998; Suppl. 17: 345.
  16. Darbee JC, Ohtake PJ, Grant BJ, Cerny FJ. Physiologic evidence for the efficacy of positive expiratory pressure as an airway clearance technique in patients with cystic fibrosis. Phys Ther 2004; 84: 524-537. Go to original source...
  17. Pryor JA, Weber BA. Physiotherapy techniques. In Pryor JA, Prasad SA. (Eds.) Physiotherapy for respiratory and cardiac problems (3rd ed.) 2002 Edinburgh: Churchill Livingstone 141-262.
  18. McCool FD, Rosen MJ. Nonpharmacologic airway clearance practice guidelines therapies: ACCP Evidence - based clinical. Chest 2006; 129: 250S-259S. Go to original source... Go to PubMed...
  19. Smolíková L, Máček M. Respirační fyzioterapie a plicní rehabilitace. Brno, Národní centrum ošetřovatelství a nelékařských zdravotnických oborů, 2010.
  20. Oberwaldner B, Evans JC, Zach MS. Forced expirations against a variable resistence: a new chest physiotherapy method in cystic fibrosis. Pediatr Pulmonol 1986; 2: 358-367. Go to original source... Go to PubMed...
  21. Cegla UH, Bautz M, Frode G, Werner T. Physiotherapy in patients with COAD and tracheobronchial instability - a comparison of two oscillating PEP systems (RC-Cornet, VRP1 Desitin). Pneumologie 1997; 51: 129-136. Go to PubMed...
  22. Newbold ME, Tullis E, Corey M, Ross B, Brooks D. The flutter device versus the PEP mask in the treatment of adults with cystic fibrosis. Physiother Canada 2005; 57: 199-207. Go to original source...
  23. www.lindegas.cz
  24. Mahimeister MJ, Fink JB, Hoffman GL, Fifer LF. Positive expiratory pressure mask therapy: theoretical and practical considerations and review of the literature. Respir Care 1991; 36: 1218-1229.
  25. Wiersgalla S. Effects EzPAP postoperatively in coronary artery bypass graft patients. (dostupné na www.rcjournal. com/abstracts/2002/? id=OF-02-084).
  26. www.smitko-medical.cz
  27. www.duchennefoundation.org.au
  28. Konstan MW, Stern RC, Doershuk CF. Efficacy of the Flutter device for airway mucus clearance in patients with cystic fibrosis. J Pediatr 1994; 124: 689-693. Go to original source... Go to PubMed...
  29. www.mv-diagnostic.cz
  30. Fauroux B, Guillemot N, Aubertin G, Nathan N, Labit A, Clément A, Lofaso F. Physiologic benefits of mechanical insufflation-exsufflation in children with neuromuscular diseases. Chest 2008; 133: 161-168. Go to original source... Go to PubMed...
  31. Miske LJ, Hickey EM, Kolb SM, et al. Use of the mechanical in - exsufflator in pediatric patients with neuromuscular disease and impaired cough. Chest 2004; 125(4): 1406-1412. Go to original source... Go to PubMed...
  32. McIlwaine M. Physiotherapy and airway clearance techniques and devices. Paediatric respiratory reviews 2006; 7S: S220-S222. Go to original source... Go to PubMed...
  33. Pryor JA. Physiotherapy for airway clearance in adults. Eur Respir J 1999; 14: 1418-1424. Go to original source... Go to PubMed...




Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.